Anti-Alzheimer's Disease Compound Library

•   A unique collection of 1374 compounds for high throughput screening (HTS) and high content screening (HCS).

•   Targets include Amyloid-β, 5-HT Receptor, nAChR,etc.

•   A useful tool for exploring the mechanism of Alzheimer's disease and looking for new treatments.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   Detailed compound information with structure, IC₅₀, and brief introduction.

•   Validated NMR and HPLC to ensure high purity and quality.

•   All compounds are in stock and continuously updated.

Formulation:

A collection of 1374 anti-Alzheimer’s Disease compounds supplied as pre-dissolved Solutions or Solid
Solution: 1354 compounds supplied in 10 mM solution, 20 compounds supplied in 2 mM solution.

Layout:

96-well storage tube or 96-well plate: 1st and 12th column are left empty.
384-well plate: the first two columns and the last two columns are left empty.
Compounds with different concentrations or dissolved in different solvents will be put on separate plates. This way of layout may increase the number of plates because there could be three solvents and three concentrations.
If you have other requirements, please let us know.

Container:

96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode

Storage:

In solvent: -80°C 2 years, -20°C 1 year; Powder: -20°C 3 years, 4°C 2 years

Shipping:

Blue ice